Biotech
Organoid culture technology is currently experiencing a technological explosion and a surge in scientific research results. The industry’s growth potential is vast, yet it also confronts significant challenges. Organoid technology has emerged as a prominent and autonomous research tool. Organoids, formed as intricate three-dimensional (3D) structures, hold the capacity to originate from a wide array [...]
By Rafaat Rahmani, CEO at Lifescience Dynamics, shares his reflections and predictions for the pharmaceutical industry. The pharmaceutical and medical industry is experiencing greater focus and priority this year, with the 2024 spring budget including a £92 million investment in facilities expansion and R&D, highlighting the need for development and manufacturing of life-saving medicines and [...]
For those of us watching the emerging treatment landscape, the past two years have seen a particular and exciting boom in the approval of innovative cell and gene therapies. Across multiple conditions, 2022 saw the US and EU grant 11 new regulatory approvals, with 2023 following closely behind with 7 Food and Drug Administration (FDA) [...]
In just four weeks' time Neuro Convention takes place at the NEC in Birmingham. Neuro Convention showcases the latest innovations in the field of neurological rehabilitation including exoskeletons, virtual reality, neuro-stimulation, gait analysis, orthotics, robot-assisted therapy, whilst also maintaining a central focus on patient care and training best practices through a CPD seminar programme. Attended [...]
A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene editing therapy, new research has revealed. The patients from the UK, New Zealand and the Netherlands have hereditary angioedema, a genetic disorder characterised by severe, painful and unpredictable swelling attacks. These attacks interfere with [...]
Clinical stage biopharma company Lyndra Therapeutics has announced the closing of a $101 million (£79,400,000) Series E financing round. The proceeds of the round, led by Sarissa Capital, will support the development of Lyndra’s pipeline, including oral weekly risperidone (LYN-005), which is near completion of a phase 3 study. Lyndra’s investigational therapies are enabled by [...]
Researchers in the US have developed a simpler, more cost-effective approach to constructing synthetic chromosomes that could significantly advance genetic engineering and enable a wide range of advances in medicine and biotechnology. CReATiNG works by cloning and reassembling natural DNA segments from yeast, enabling scientists to create synthetic chromosomes that can replace their native counterparts [...]
NPL and Jellagen have published breakthrough data demonstrating the potential of collagen derived from jellyfish to support next-generation research and medical applications. New research by the National Physical Laboratory (NPL) and biotechnology company Jellagen Ltd has revealed the potential of jellyfish collagen as the foundation for a range of new medical applications and to support new [...]
Opening up problems to people outside of the organisation, or even the sector, could yield better and faster results for biopharma companies. Crowdsourcing has become an essential part of the R&D process in many sectors, but biopharma and the life sciences are lagging behind as they continue to rely on a closed, traditional approach. A [...]
LiliumX, an innovative BioTech start-up focused on the development of next generation antibody-based therapeutics, has unveiled its new brand name and welcomed three top industry leaders to the business, after securing $7.8 million (£6.3 million) in investment. LiliumX was founded in 2021 by co-founders Arne Scheu and Irsyad Khairil, following their own research into “LEGO” [...]
